These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4172137)

  • 1. Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.
    Levi AJ; Sherlock S; Walker D
    Lancet; 1968 Jun; 1(7555):1275-9. PubMed ID: 4172137
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired elimination of meperidine in patients with liver disease.
    McHorse TS; Klotz U; Wilkinson G; Schenker S
    Trans Assoc Am Physicians; 1974; 87():281-7. PubMed ID: 4456737
    [No Abstract]   [Full Text] [Related]  

  • 3. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW; Axelsen E
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolism of phenylbutazone in the liver (author's transl)].
    González Macías J; De Castro del Pozo S
    Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.
    Cook GC; Mulligan R; Sherlock S
    Q J Med; 1971 Apr; 40(158):159-85. PubMed ID: 4933363
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic function tests.
    Burke MD
    Geriatrics; 1974 Jan; 29(1):75-80. PubMed ID: 4148622
    [No Abstract]   [Full Text] [Related]  

  • 8. Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease.
    Jones EA; Cain GD; Dickinson G
    Gastroenterology; 1972 Apr; 62(4):612-7. PubMed ID: 5020873
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anabolic steroids and liver diseases].
    Wewalka F
    Wien Med Wochenschr; 1967 Mar; 117(12):293-9. PubMed ID: 4871957
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum arginase concentrations in acute alcoholism.
    Rothfeld B; Carulli N; Kaihara S; Reus I; Wagner HN
    Biochem Med; 1970 Aug; 4(1):36-42. PubMed ID: 5524058
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.
    Korman MG; Hofmann AF; Summerskill WH
    N Engl J Med; 1974 Jun; 290(25):1399-402. PubMed ID: 4133590
    [No Abstract]   [Full Text] [Related]  

  • 12. [Liver in active hyperthyreosis].
    Meng W; Lorenz G; Eggert H; Meng S; Hampel R; Baufeld W
    Z Gesamte Inn Med; 1973 Dec; 28(24):787-91. PubMed ID: 4130587
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in the rate of ethanol metabolism in recently drinking alcoholic and nondrinking subjects.
    Kater RM; Carulli N; Iber FL
    Am J Clin Nutr; 1969 Dec; 22(12):1608-17. PubMed ID: 5362487
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of renal and hepatic disease on vitamin-B12 metabolism.
    Adams JF
    Lancet; 1968 Aug; 2(7563):328-9. PubMed ID: 4173740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acetphenolisatin and liver damage].
    Fabricius-Bjerre N; Hertel K
    Ugeskr Laeger; 1973 Dec; 135(50):2745-6. PubMed ID: 4780574
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiphasic testing for liver-related abnormalities in hemorrhoidal disease.
    Ganchrow MI; Bowman HE
    Surg Gynecol Obstet; 1971 Mar; 132(3):478-82. PubMed ID: 5546301
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled trial of prednisone and azathioprine in active chronic hepatitis.
    Murray-Lyon IM; Stern RB; Williams R
    Lancet; 1973 Apr; 1(7806):735-7. PubMed ID: 4121073
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucaric acid as an indicator of use of enzyme-inducing drugs.
    Sotaniemi EA; Medzihradsky F; Eliasson G
    Clin Pharmacol Ther; 1974 Apr; 15(4):417-23. PubMed ID: 4150733
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical-chemical studies in liver diseases].
    Kreutz FH
    Internist (Berl); 1966 Jan; 7(1):13-21. PubMed ID: 4861681
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase in skin surface lipids during nutritional rehabilitation of male alcoholics.
    Kraus SJ
    J Invest Dermatol; 1969 Jul; 53(1):46-50. PubMed ID: 5793136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.